SEC Form 4 · accession 0001140361-15-042666
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
Nov 19, 2015
Accepted (ET)
Nov 23, 2015 · 8:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | holding | — | — | — | 74,287 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $58.24 | Nov 19, 2015 | A | 30,149 | A | Nov 11, 2016 | Nov 19, 2022 | ResMed Common Stock | 30,149 | 30,149 | D |
Explanation of responses
- F1Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2016, 2017 and 2018.